GI ONCOLOGY

Browse all GI ONCOLOGY
Over The Counter Medication: A Game-Changer for PI3K-Altered Colorectal Cancer?

GI ONCOLOGY

Over The Counter Medication: A Game-Changer for PI3K-Altered Colorectal Cancer?

Sawyer Bawek, DO

Latest GI Cancer Trends From ASCO 2025: Molecular Testing, IO Strategies & Targeted Therapy

GI ONCOLOGY

Latest GI Cancer Trends From ASCO 2025: Molecular Testing, IO Strategies & Targeted Therapy

Seyi Abidoye, MBBS

ASCO 2025 Highlights: Breakthroughs in GI Oncology From BREAKWATER, MATTERHORN, ATOMIC & CHALLENGE

GI ONCOLOGY

ASCO 2025 Highlights: Breakthroughs in GI Oncology From BREAKWATER, MATTERHORN, ATOMIC & CHALLENGE

Sawyer Bawek, DO

GU ONCOLOGY

Browse all GU ONCOLOGY
Breakthroughs in Bladder, Prostate, and Kidney Cancer: What Oncologists Need to Know From ASCO 2025

GU ONCOLOGY

Breakthroughs in Bladder, Prostate, and Kidney Cancer: What Oncologists Need to Know From ASCO 2025

Saad Atiq, MD

Durvalumab Enters the Perioperative Landscape in Muscle-Invasive Bladder Cancer: Reflections from the NIAGARA Trial and ASCO 2025 Updates

GU ONCOLOGY

Durvalumab Enters the Perioperative Landscape in Muscle-Invasive Bladder Cancer: Reflections from the NIAGARA Trial and ASCO 2025 Updates

Charbel Matar, MD

BREAST CANCER

Browse all BREAST CANCER
Updates in Breast Cancer From ASCO 2025

BREAST CANCER

Updates in Breast Cancer From ASCO 2025

Zunairah Shah, MD

Advancements in Oncology at ASCO 2025: Breast Cancer Highlights

BREAST CANCER

Advancements in Oncology at ASCO 2025: Breast Cancer Highlights

Tanmayi Pai, MD

Advances in Managing CNS Metastases in Breast Cancer: SABCS 2024 Insights

BREAST CANCER

Advances in Managing CNS Metastases in Breast Cancer: SABCS 2024 Insights

Hetal Mistry, MD

HEMATOLOGY

Browse all HEMATOLOGY
Real-World Evidence Supports Outpatient Axicabtagene Ciloleucel (Yescarta) Administration for Relapsed/Refractory LBCL

HEMATOLOGY

Real-World Evidence Supports Outpatient Axicabtagene Ciloleucel (Yescarta) Administration for Relapsed/Refractory LBCL

Sawyer Bawek, DO

The Impact of Novel Agents in Non-Hodgkin Lymphoma Treatment

HEMATOLOGY

The Impact of Novel Agents in Non-Hodgkin Lymphoma Treatment

Anuja V. Abhyankar, MD

Management of Multiple Myeloma: From Newly Diagnosed to Relapsed/Refractory Disease

HEMATOLOGY

Management of Multiple Myeloma: From Newly Diagnosed to Relapsed/Refractory Disease

Vaishali Deenadayalan, MD

LUNG CANCER

Browse all LUNG CANCER
Thoracic Oncology in 2025: Evolving Standards and Practice-Changing Data From ASCO

LUNG CANCER

Thoracic Oncology in 2025: Evolving Standards and Practice-Changing Data From ASCO

Kriti Ahuja, MD

Shifting Paradigms in Lung Cancer Care: Insights From ASCO 2025

LUNG CANCER

Shifting Paradigms in Lung Cancer Care: Insights From ASCO 2025

Maria A. Velez, MD, MS

IMforte Trial: A Potential First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

LUNG CANCER

IMforte Trial: A Potential First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Sawyer Bawek, DO

Beamion Lung-1: Zongertinib Emerges as a Promising Option in HER2 NSCLC

LUNG CANCER

Beamion Lung-1: Zongertinib Emerges as a Promising Option in HER2 NSCLC

Sawyer Bawek, DO